78
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Nested Case–Control Study of Corin Combined with sFlt-1/PLGF in Predicting the Risk of Preeclampsia

, , &
Pages 2313-2320 | Published online: 03 Jun 2021

References

  • Steegers EAP, von Dadelszen P, Duvekot JJ, Pijnenborg R. Preeclampsia. Am J Pathol. 2010;176(2):710–720. doi:10.2353/ajpath.2010.090513
  • Ramos JGL, Sass N, Costa SHM. Preeclampsia. Rev Bras Ginecol Obstet. 2017;39(9):496–512. doi:10.1055/s-0037-1604471
  • Filipek A, Jurewicz E. [Preeclampsia - a disease of pregnant women]. Postepy Biochem. 2018;64(4):232. English. doi:10.18388/pb.2018_146
  • Powel JE, Rosenthal E, Roman A, Chasen ST, Berghella V. Preeclampsia and low sodium (PALS): a case and systematic review. Eur J Obstet Gynecol Reprod Biol. 2020;249:14–20. doi:10.1016/j.ejogrb.2020.03.052
  • Sibai BM, Stella CL. Diagnosis and management of atypical preeclampsia-eclampsia. Am J Obstet Gynecol. 2009;200(5):481.e1–7. doi:10.1016/j.ajog.2008.07.048
  • Rana S, Lemoine E, Granger JP, Ananth Karumanchi S. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res. 2019;124(7):1094–1112. doi:10.1161/CIRCRESAHA.118.313276
  • El-Sayed AAF. Preeclampsia: a review of the pathogenesis and possible management strategies based on its pathophysiological derangements. Taiwan J Obstet Gynecol. 2017;56(5):593–598. doi:10.1016/j.tjog.2017.08.004
  • Herraiz I, Llurba E, Verlohren S, Galindo A; Spanish Group for the Study of Angiogenic Markers in Preeclampsia. Update on the diagnosis and prognosis of preeclampsia with the aid of the sFlt-1/PlGF ratio in singleton pregnancies. Fetal Diagn Ther. 2018;43(2):81–89. doi:10.1159/000477903
  • Lecarpentier É, Vieillefosse S, Haddad B, et al. Placental Growth Factor (PlGF) and sFlt-1 during pregnancy: physiology, assay and interest in preeclampsia. Ann Biol Clin. 2016;74(3):259–267.
  • Cui L, Shu C, Liu Z, et al. The expression of serum sEGFR, sFlt-1, sEndoglin and PLGF in preeclampsia. Pregnancy Hypertens. 2018;13:127–132. doi:10.1016/j.preghy.2018.05.011
  • Lecarpentier E, Tsatsaris V. Angiogenic balance (sFlt-1/PlGF) and preeclampsia. Ann Endocrinol. 2016;77(2):97–100. doi:10.1016/j.ando.2016.04.007
  • Zhou Y, Wu Q. Role of corin and atrial natriuretic peptide in preeclampsia. Placenta. 2013;34(2):89–94. doi:10.1016/j.placenta.2012.11.016
  • Chalova KI, Pehlivanov BK, Amaliev IG, Amaliev GI, Raycheva RD, Ivanovska MV. Maternal serum concentrations of corin, endoglin, PP13, and sFlt-1 and their changes with advancement of pregnancy and correlation with doppler of uterine arteries. Folia Med. 2018;60(4):558–564. doi:10.2478/folmed-2018-0025
  • Cui Y, Wang W, Dong N, et al. Role of corin in trophoblast invasion and uterine spiral artery remodelling in pregnancy. Nature. 2012;484(7393):246–250. doi:10.1038/nature10897
  • Méhats C, Miralles F, Vaiman D. [New perspectives on preeclampsia]. Med Sci. 2017;33(12):1079–1088. English.
  • Hui L, Zhang Y, Qingyu W. Role of corin in the regulation of blood pressure. Curr Opin Nephrol Hypertens. 2017;26(2):67–73. doi:10.1097/MNH.0000000000000297
  • Miyazaki J, Nishizawa H, Kambayashi A, et al. Increased levels of soluble corin in pre-eclampsia and fetal growth restriction. Placenta. 2016;48:20–25. doi:10.1016/j.placenta.2016.10.002
  • Verlohren S, Perschel FH, Thilaganathan B, et al. Angiogenic markers and cardiovascular indices in the prediction of hypertensive disorders of pregnancy. Hypertension. 2017;69(6):1192–1197. doi:10.1161/HYPERTENSIONAHA.117.09256
  • Taravati A, Tohidi F. Comprehensive analysis of oxidative stress markers and antioxidants status in preeclampsia. Taiwan J Obstet Gynecol. 2018;57(6):779–790. doi:10.1016/j.tjog.2018.10.002
  • Sonek J, Krantz D, Carmichael J, et al. First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental. Am J Obstet Gynecol. 2018;218(1):126.e1–126.e13. doi:10.1016/j.ajog.2017.10.024
  • Zhao M, Zhu Z, Liu C, Zhang Z. Dual-cutoff of sFlt-1/PlGF ratio in the stratification of preeclampsia: a systematic review and meta-analysis. Arch Gynecol Obstet. 2017;295(5):1079–1087. doi:10.1007/s00404-017-4302-3
  • Doherty A, Carvalho JCA, Drewlo S, et al. Altered hemodynamics and hyperuricemia accompany an elevated sFlt-1/PlGF ratio before the onset of early severe preeclampsia. J Obstet Gynaecol Can. 2014;36(8):692–700. doi:10.1016/S1701-2163(15)30511-9
  • Liu Y, Zhao Y, Ailing Y, Zhao B, Gao Y, Niu H. Diagnostic accuracy of the soluble fms-like tyrosine kinase-1/placental growth factor ratio for preeclampsia: a meta-analysis based on 20 studies. Arch Gynecol Obstet. 2015;292(3):507–518. doi:10.1007/s00404-015-3671-8
  • Khalil A, Maiz N, Garcia-Mandujano R, Elkhouli M, Nicolaides KH. Longitudinal changes in maternal corin and mid-regional proatrial natriuretic peptide in women at risk of pre-eclampsia. Ultrasound Obstet Gynecol. 2015;45(2):190–198. doi:10.1002/uog.14685
  • Armaly Z, Assady S, Abassi Z. Corin: a new player in the regulation of salt-water balance and blood pressure. Curr Opin Nephrol Hypertens. 2013;22(6):713–722. doi:10.1097/01.mnh.0000435609.35789.32
  • Rong Y, Han X, Zhang X, Wang Y, Wang T. Circulating soluble corin as a potential biomarker for cardiovascular diseases: a translational review. Clin Chim Acta. 2018;485:106–112. doi:10.1016/j.cca.2018.06.036